Attendance form View-text xml

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>

<item>
<title>Effect of Tirzepatide in Chinese Adults With Obesity</title>
<link>https://jamanetwork.com/journals/jama/fullarticle/2819431</link>
<pubDate>Tue, 20 Aug 2024 00:00:00 GMT</pubDate>
<description>This randomized clinical trial investigates the safety and efficacy of treatment with once-weekly tirzepatide for weight reduction in Chinese adults with overweight or obesity without diabetes over a 52-week period.</description>
<prism:volume xmlns:prism=”prism”>332</prism:volume>
<prism:number xmlns:prism=”prism”>7</prism:number>
<prism:startingPage xmlns:prism=”prism”>551</prism:startingPage>
<prism:endingPage xmlns:prism=”prism”>560</prism:endingPage>
<prism:doi xmlns:prism=”prism”>10.1001/jama.2024.9217</prism:doi>
<guid>2819431</guid>
</item>